{
    "2018-02-13": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Zacks.com highlights: Jones Lang LaSalle, Intel, Dollar General, AbbVie and Owens Corning",
                "features": {
                    "keywords": [
                        "Jones Lang LaSalle",
                        "Intel",
                        "Dollar General",
                        "AbbVie",
                        "Owens Corning"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "real estate",
                        "technology",
                        "retail",
                        "pharmaceuticals",
                        "materials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Better Buy: Eli Lilly and Company vs. Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Johnson & Johnson",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Bristol-Myers Squibbâ€™s Virology Products in 4Q17",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Virology Products",
                        "4Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}